SILVERDALE MEDICAL PRACTICE — All Prescriptions & Medications — Page 11
Practice Code: P87019 | MANCHESTER, M27 8HP
Showing results 501-550 of 666
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Citalopram hydrochloride | 23 | 765 | £532 | +43.3% ▲ |
| Atomoxetine hydrochloride | 23 | 700 | £1.5K | -32.0% ▼ |
| Combined ethinylestradiol 35mcg | 23 | 1,365 | £79 | +84.6% ▲ |
| Sodium chloride | 23 | 1,340 | £809 | -22.7% ▼ |
| Adapalene | 23 | 1,035 | £359 | +5.1% ▲ |
| 23 | 284 | £553 | +160.0% ▲ | |
| Zinc oxide | 22 | 1,009 | £106 | +6.3% ▲ |
| Dronedarone hydrochloride | 22 | 980 | £1.1K | +52.3% ▲ |
| Oxcarbazepine | 22 | 1,614 | £576 | -21.3% ▼ |
| Ferric maltol | 22 | 1,456 | £1.2K | +69.1% ▲ |
| Etoricoxib | 22 | 700 | £142 | -72.7% ▼ |
| 22 | 960 | £2.0K | +35.8% ▲ | |
| Rivastigmine | 21 | 647 | £908 | -69.5% ▼ |
| Colistimethate sodium | 21 | 1,260 | £7.4K | +85.7% ▲ |
| Ibandronic acid | 21 | 46 | £50 | -42.2% ▼ |
| RtS 2-2.4 kcal/ml m/sk higher protein,higher energy(0913011) | 21 | 406.0K | £5.7K | -52.0% ▼ |
| Diclofenac sodium | 21 | 400 | £119 | -58.6% ▼ |
| Ivermectin | 21 | 960 | £556 | -1.2% vs avg |
| Lidocaine | 21 | 995 | £794 | +82.7% ▲ |
| 21 | 92 | £318 | +162.7% ▲ | |
| 21 | 1,538 | £3.2K | -37.8% ▼ | |
| 21 | 590 | £349 | -19.4% ▼ | |
| 21 | 630 | £3.1K | +77.3% ▲ | |
| 21 | 840 | £2.1K | +37.9% ▲ | |
| Bempedoic acid/Ezetimibe | 20 | 1,036 | £1.9K | -67.2% ▼ |
| Inclisiran | 20 | 20 | £1.0K | +58.8% ▲ |
| Eslicarbazepine acetate | 20 | 900 | £1.3K | -10.4% ▼ |
| Bupropion hydrochloride | 20 | 1,380 | £913 | +85.0% ▲ |
| Urine testing reagents | 20 | 1,000 | £57 | +78.9% ▲ |
| Mupirocin | 20 | 66 | £89 | +70.4% ▲ |
| 20 | 144 | £310 | +36.9% ▲ | |
| Linaclotide | 19 | 784 | £999 | +4.0% ▲ |
| Mebendazole | 19 | 344 | £20 | +66.0% ▲ |
| Estradiol valerate | 19 | 1,596 | £132 | -2.7% ▼ |
| Powder 2.3 - 2.4 kcal/ml milkshake lower volume (0913011) | 19 | 812 | £420 | -26.0% ▼ |
| Ready to serve 2.4 kcal/ml milkshake higher volume (0913011) | 19 | 122.5K | £745 | -6.1% ▼ |
| Tablets OTC glucose for diabetic hypo treatment (0913541) | 19 | 758 | £46 | +26.5% ▲ |
| Indometacin | 19 | 868 | £57 | +20.7% ▲ |
| Tafluprost | 19 | 1,140 | £464 | +2.5% ▲ |
| 19 | 492 | £1.5K | -31.3% ▼ | |
| 19 | 720 | £2.3K | +65.9% ▲ | |
| Desloratadine | 18 | 945 | £82 | -37.6% ▼ |
| Imipramine hydrochloride | 18 | 1,400 | £52 | -29.4% ▼ |
| Phased formulations of ethinylestradiol | 18 | 1,323 | £77 | +303.3% ▲ |
| 18 | 250 | £258 | +64.4% ▲ | |
| 18 | 200 | £134 | -58.2% ▼ | |
| 18 | 1,260 | £4.3K | -26.1% ▼ | |
| Rizatriptan | 17 | 294 | £566 | -71.4% ▼ |
| Varenicline tartrate | 17 | 465 | £412 | +71.7% ▲ |
| Doxycycline monohydrate | 17 | 606 | £340 | +56.6% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.